Nanjing First Hospital, Nanjing Medical University: Diabetes Mellitus trials

The registry lists 22 Diabetes Mellitus studies with Nanjing First Hospital, Nanjing Medical University as lead sponsor. 7 are open to participants now and 1 have results posted.

Phase 3 3Phase 4 4No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Characteristics of Papez Loop Neural Network in T2DM （Type 2 Diabetes Mellitus）RecruitingNCT06912321
• Current Status of Islet Alpha Cell Function in Patients with Type 2 DiabetesRecruitingNCT06825182Phase 3
• The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).Not yet recruitingNCT06606509
• IVI-guided Versus Angiography-guided PCI in Patients With Diabetes MellitusRecruitingNCT06380868Not applicable
• The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes MellitusNot yet recruitingNCT06182852
• The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic StrategiesRecruitingNCT06173934Not applicable
• Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 YearsRecruitingNCT05990374Not applicable
• Lipoprotein-associated Phospholipase A2 in Patients With Type 2 DiabetesCompletedNCT03362112Results posted
• Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 DiabetesStatus unknownNCT05629806Phase 3
• Effect of Metformin, Dapagliflozin, Combination of Metformin and Pioglitazone in Patients With Type 2 DiabetesStatus unknownNCT05591235Phase 3
• The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin TherapyStatus unknownNCT05578352Not applicable
• The Different Response of Endocrine Hormones to Hypoglycemia in Patients With Type 1 or Type 2 DiabetesCompletedNCT05290207
• Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and AcarboseCompletedNCT05035849Not applicable
• Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes MellitusCompletedNCT04847219Not applicable
• Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes MellitusStatus unknownNCT04120623Phase 4
• The Exploration of Optimal Treatment Scheme in Patients With Type 2 Diabetes Inadequately Controlled With GlargineStatus unknownNCT03659383Phase 4
• The Blood Glucose Control in Patients With Type 2 Diabetes Treated With GlargineStatus unknownNCT03566472
• Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 DiabetesCompletedNCT03519529
• Influence of Injection Technique of Premixed Insulin on Glucose Excursion in Type 2 Diabetes MellitusStatus unknownNCT03513055Not applicable
• Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 DiabetesCompletedNCT03226210Phase 4
• Thyroid Function and Diabetes ComplicationsCompletedNCT03001336
• Berberine Prevent Contrast-induced Nephropathy in Patients With DiabetesCompletedNCT02808351Phase 4